US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 5.880
  • -0.320-5.16%
Close Mar 25 16:00 ET
  • 5.880
  • 0.0000.00%
Post 16:05 ET
125.44MMarket Cap-1.19P/E (TTM)

Enanta Pharmaceuticals Key Stats

Enanta Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 15.609M--
May 12, 20252025/Q2-- / 15.961M--
--2025/Q116.959M / 17.249M--
Nov 25, 20242024/Q414.607M / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 15.609M--
May 12, 20252025/Q2-- / 15.961M--
--2025/Q116.959M / 17.249M--
Nov 25, 20242024/Q414.607M / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--

Unlock Free Earnings Estimates

Enanta Pharmaceuticals Earnings Reports

Read more

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More